111 Inc banner

111 Inc
NASDAQ:YI

Watchlist Manager
111 Inc Logo
111 Inc
NASDAQ:YI
Watchlist
Price: 6.7 USD -2.19% Market Closed
Market Cap: $29m

111 Inc
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

111 Inc
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
111 Inc
NASDAQ:YI
Other
-¥83.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Other
-¥1.5B
CAGR 3-Years
-18%
CAGR 5-Years
-80%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Other
-¥1.7B
CAGR 3-Years
N/A
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Other
¥233m
CAGR 3-Years
N/A
CAGR 5-Years
59%
CAGR 10-Years
-10%
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Other
-¥1.3B
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Other
-¥232.5m
CAGR 3-Years
-17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

111 Inc
Glance View

Market Cap
29m USD
Industry
Retail

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2018-09-12. The firm is mainly engaged in the provision of online medical services, drug purchasing and health management services through Internet and information technology. The firm mainly conducts its business in the domestic market.

YI Intrinsic Value
HIDDEN
Show

See Also

What is 111 Inc's Other?
Other
-83.5m CNY

Based on the financial report for Sep 30, 2025, 111 Inc's Other amounts to -83.5m CNY.

What is 111 Inc's Other growth rate?
Other CAGR 1Y
77%

Over the last year, the Other growth was 77%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett